Caption Health announced today that it partnered with Heartbeat Health to provide earlier access to cardiovascular care. Brisbane, California–based Caption Health will provide its Caption Care for clinicians to perform heart ultrasounds in convenient locations — including a patient’s home — using the Caption AI platform. Heartbeat Health virtual cardiologists will receive, read and interpret […]
Software / IT
FDA clears Viz.ai’s algorithm that detects subdural hemorrhage
Viz.ai announced today that it received FDA 510(k) clearance for its Viz Subdural (SDH) artificial intelligence (AI) algorithm. San Francisco-based Viz.ai designed its Viz SDH algorithm to use AI to automatically detect subdural hemorrhage, enabling physicians to triage patients effectively and deliver optimal care. The company said in a news release that its Viz SDH […]
Abbott launches digital health app for neurostimulation in Canada
Abbott (NYSE:ABT) announced today that it received Health Canada licensing for its NeuroSphere Virtual Clinic, enabling it to launch the app. The Abbott Park, Illinois–based company designed the remote programming technology — the first of its kind in Canada — with compatibility with Abbott’s suite of neuromodulation technologies, offering the potential to increase access to […]
Viz.ai, Hyperfine partner on new MRI, workflow paradigm
Viz.ai announced today that it partnered with Hyperfine (Nasdaq:HYPR) to bring magnetic resonance imaging (MRI) to the patient’s bedside. San Francisco-based Viz.ai develops the Viz LVO, its flagship product designed to leverage advanced deep learning to communicate time-sensitive information about stroke patients straight to a specialist who can intervene and treat the patient. Hyperfine develops […]
Exo acquires Medo AI to improve ultrasound imaging
Exo announced today that it will acquire artificial intelligence (AI) developer Medo to make ultrasound imaging faster and simpler. Redwood City, California-based Exo intends to integrate Medo’s proprietary Sweep AI technology into its ultrasound platform to make the imaging modality more accessible to a wider range of caregivers. No financial terms for the acquisition were […]
Pear Therapeutics announces layoffs
Prescription digital therapeutics company Pear Therapeutics (Nasdaq:PEAR) announced today that it is letting go of roughly 25 employees, representing 9% of its workforce. The layoffs are part of an overall operations restructuring that the Boston-based company said will “narrow its near-term business focus and reduce its workforce due to the macroeconomic environment,” according to an […]
Cleerly raises $223M for AI-based software to spot atherosclerosis
Cleerly announced today that it closed an oversubscribed Series C financing round with proceeds of $223 million. New York-based Cleerly has now raised $279 million in total, including its Series B round in 2021. The company develops an AI-enabled approach for evaluating coronary computed tomography (CT) angiograms, allowing physicians to more easily identify, characterize and […]
Calyx, Qynapse partner on AI-enhanced imaging for clinical trials
Calyx announced today that it partnered with Qynapse to use AI-powered neuroimaging analysis technology for central nervous system disorders. The partnership will combine Calyx’s eClinical and regulatory solutions and services with Qynapse’s artificial intelligence (AI)-based QyScore and QyPredict platforms for customers developing medical treatments for central nervous system (CNS) disorders. “We’re delighted to add Qynapse’s […]
Surgical intelligence platform developer Theator raises $39.5M
Theator announced today that it raised $24 million in an extension of its Series A, bringing the round to $39.5 million raised in total. Palo Alto, California-based Theator announced the initial $15.5 million Series A in February 2021, with the extended round led by Insight Partners. Existing investors including Blumberg Capital, Mayo Clinic, NFX, StageOne […]
FDA clears iRhythm’s ZEUS system for Zio Watch
iRhythm Technologies (Nasdaq:IRTC) announced today that it received FDA 510(k) clearance for its ZEUS (Zio ECG Utilization Software) system. ZEUS, produced in partnership with Google’s life sciences sister company Verily, combines deep-learned algorithms with iRhythm’s cardiac arrhythmia service, providing the AI algorithm component for the Zio Watch sensor-based wearable for non-invasive, clinical-grade, long-term continuous monitoring […]
FDA clears RapidAI platform for assessing neuro injury severity
RapidAI announced today that it received FDA clearance for its Rapid Hyperdensity, a new addition to its RapidAI platform. San Mateo, California-based RapidAI designed Rapid Hyperdensity to give physicians a tool to quickly assess the severity of injury in patients with acute neuro conditions, such as traumatic brain injury and brain hemorrhages, to allow for […]